James Bylund serves as the Chief Operating Officer (COO) at Repligen Corporation, a global life sciences company focused on bioprocessing technology and solutions. In his role as COO, Bylund is responsible for overseeing the company's operational strategies, ensuring efficient execution of business plans, and driving the organization's growth. His leadership has been instrumental in guiding Repligen through a period of significant expansion and innovation, particularly in the development and commercialization of products that enhance the efficiency and productivity of biopharmaceutical manufacturing processes. Before joining Repligen, Bylund built a robust career in the life sciences and biopharmaceutical industries. He holds a Bachelor of Science degree in Chemical Engineering from the University of Minnesota and an MBA from the Carlson School of Management at the same university. His professional journey includes key positions at leading companies such as MilliporeSigma, where he honed his expertise in operations management, strategic planning, and business development. Bylund's deep understanding of the bioprocessing sector, combined with his strategic vision, has enabled him to make significant contributions to Repligen's success, including the successful integration of acquisitions and the launch of new, innovative products. Under Bylund's leadership, Repligen has continued to strengthen its position as a leader in the bioprocessing industry. He has been pivotal in driving initiatives that enhance the company's manufacturing capabilities and global reach, ensuring that Repligen remains at the forefront of delivering high-quality, reliable solutions to its customers. His commitment to operational excellence and his ability to foster a culture of innovation and collaboration have been key factors in Repligen's ongoing growth and success.